Plasma cell leukemia (PCL) is a rare disease that may present de novoor secondary to plasma cell myeloma. Advanced disease and extramedullary involvement are common clinical features at presentation.

Although the cause of multiple myeloma is not known, research shows that genetic changes in the DNA of a single plasma cell ...

Follow along on our guide to Multiple Myeloma, a cancer of the bone marrow's infection-fighting plasma cells. As cancerous ...

Multiple myeloma is a plasma cell disorder, and plasma cells are cells that live within the bone marrow and their job is to make antibodies. So, when you get sick or you get a vaccine, the cells ...

Multiple myeloma (MM) is a blood cancer that affects plasma cells in bone marrow. It’s a particularly insidious form of ...

The most effective means of improving host defense in myeloma may be reduction of the number of neoplastic plasma cells and levels of anomalous globulins in the serum with chemotherapy.

SkylineDx has published a new study marking a “significant advancement” in the understanding and identification of high-risk ...

More than a year into a strategic pivot to zero in on the multiple myeloma cell therapy Abecma, 2seventy bio is selling ...

During a Case-Based Roundtable® event, Robert Z. Orlowski, MD, PhD, discussed the case of a patient who had progression of ...

T-cell therapy could potentially be moved to earlier lines of treatment in relapsed/refractory multiple myeloma based on emerging trial data, improving outcomes through earlier intervention before ...

Multiple myeloma is a type of blood cancer that forms in plasma cells, white blood cells that produce infection-fighting antibodies. Multiple myeloma is not hereditary, meaning it is not passed ...